您的位置: 首页 > 2021年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

五苓散治疗蛛网膜下腔出血并发脑耗盐综合征

Wuling powder treating subarachnoid hemorrhage complicated with cerebral salt wasting syndrome

来源期刊: 广州医药 | 80-82 发布时间:2021-11-24 收稿时间:2025/11/13 18:03:34 阅读量:7
作者:
关键词:
五苓散蛛网膜下腔出血脑耗盐综合征六经辩证阴阳
Wuling powdersubarachnoid hemorrhagecerebral salt wasting syndromesix classics dialecticsyin and yang
DOI:
10.3969/j.issn.1000-8535.2021.05.017
收稿时间:
2021-03-03 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 通过探讨发病机制和结合1例蛛网膜下腔出血并发脑耗盐综合征病例分析,提高临床上对此类少见疾病的认识。方法 回顾性分析蛛网膜下腔出血并发脑耗盐综合征病例,运用“阴阳”、“六经”理论阐述疾病的中医病机及五苓散的中西医作用机制。结果 通过回顾性对比,使用五苓散组的患者明显比其他患者的病程短(五苓散组7.83±2.25天,对照组11.84±2.51天,P<0.05),差异有统计学意义,说明五苓散能够缩短脑耗盐综合征的病程。结论 五苓散治疗蛛网膜下腔出血合并脑耗盐综合征有良好的前景,未来可以通过前瞻性病例对照研究进一步明确其疗效。
Objective By investigating the pathogenesis and analyzing a case of subarachnoid hemorrhage complicated with cerebral salt wasting syndrome, to improve the clinical understanding of this rare disease. Methods A retrospective analysis of cases of subarachnoid hemorrhage complicated with cerebral salt wasting syndrome was made, using the theory of “yin and yang” and “six classics” to explain the pathogenesis of the disease and the mechanism of Chinese and Western medicine of Wuling powder. Results Through retrospective comparison, patients in the Wuling powder group had a shorter course of disease than other patients [(7.83±2.25) days in the Wuling powder group, (11.84±2.51) days in the control group, P<0.05], and there was a significant statistical difference, indicating that Wuling powder can shorten the course of cerebral salt wasting syndrome. Conclusion Wuling powder has a good prospect in the treatment of subarachnoid hemorrhage complicated with cerebral salt wasting syndrome, and its efficacy can be further clarified through prospective case-control studies in the future.
1、 钱天来.伤寒溯源集[M]. 北京:学苑出版社,2009:370. 钱天来.伤寒溯源集[M]. 北京:学苑出版社,2009:370.
2、 黄帝内经[M].北京:人民卫生出版社,1999:134. 黄帝内经[M].北京:人民卫生出版社,1999:134.
3、 熊曼琪.伤寒学[M]. 2版. 北京:中国中医药出版社,2011: 220. 熊曼琪.伤寒学[M]. 2版. 北京:中国中医药出版社,2011: 220.
4、 朱海峰,朱同宣,朱冬霞. 五苓散的双向调节作用[J].时珍国医国药,1998,9(6):1358. 朱海峰,朱同宣,朱冬霞. 五苓散的双向调节作用[J].时珍国医国药,1998,9(6):1358.
5、 王元飞,刘舫.五苓散的现代药理实验研究与临床应用概述[J].环球中医药,2010,3(1):70-72. 王元飞,刘舫.五苓散的现代药理实验研究与临床应用概述[J].环球中医药,2010,3(1):70-72.
6、 MORITZ M L.Syndrome of inappropriate antidiuresis[J]. Pediatr Clin North Am,2019,66(1):209-226. MORITZ M L.Syndrome of inappropriate antidiuresis[J]. Pediatr Clin North Am,2019,66(1):209-226.
7、 LIAMIS G,BARKAS F,MEGAPANOU E,et al. Hyponatremia in acute stroke patients: pathophysiology, clinical significance, and management options[J]. Eur Neurol,2019,82(1-3):32-40. LIAMIS G,BARKAS F,MEGAPANOU E,et al. Hyponatremia in acute stroke patients: pathophysiology, clinical significance, and management options[J]. Eur Neurol,2019,82(1-3):32-40.
8、 HANAKO N J,HIROSHI O,KAZUKI H I. Cerebral salt-wasting syndrome and inappropriate antidiuretic hormone syndrome after subarachnoid hemorrhaging[J].Intern Med,2017,56(6):677-680. HANAKO N J,HIROSHI O,KAZUKI H I. Cerebral salt-wasting syndrome and inappropriate antidiuretic hormone syndrome after subarachnoid hemorrhaging[J].Intern Med,2017,56(6):677-680.
9、 ZHEN J H,YAN J.Cerebral salt-wasting syndrome in a critically ill patient: an easily neglected syndrome in intensive care unit (ICU)[J].J Natl Med Assoc,2020,112(3):258-261. ZHEN J H,YAN J.Cerebral salt-wasting syndrome in a critically ill patient: an easily neglected syndrome in intensive care unit (ICU)[J].J Natl Med Assoc,2020,112(3):258-261.
10、 HYUNSOO O H,WHASOOK S E.An integrative review of cerebral salt wasting syndrome[J].J Neurosci Nurs,2020,52(6):289-294. HYUNSOO O H,WHASOOK S E.An integrative review of cerebral salt wasting syndrome[J].J Neurosci Nurs,2020,52(6):289-294.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录